Endocyte Inc. appointed Patrick Machado as a director.
Most recently, Machado was the co-founder, chief business officer and CFO of Medivation Inc. and served as a member of Medivation's board until its acquisition by Pfizer Inc. in 2016.
Endocyte appoints director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Endocyte Inc. appointed Patrick Machado as a director.
Most recently, Machado was the co-founder, chief business officer and CFO of Medivation Inc. and served as a member of Medivation's board until its acquisition by Pfizer Inc. in 2016.